Perioperative Management of Patients with Glioblastoma.
Awake brain surgery
Glioblastoma
Temozolamide
Journal
Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
1
10
2021
Statut:
ppublish
Résumé
The clinical presentation of glioblastomas is varied, and definitive diagnosis requires pathologic examination and study of the tissue. Management of glioblastomas includes surgery and adjuvant chemotherapy and radiotherapy, with surgery playing an important role in the prognosis of these patients. Awake craniotomy plays a crucial role in tumors in or adjacent to eloquent areas, allowing surgeons to maximize resection, while minimizing iatrogenic deficits. However, the prognosis remains dismal. This article presents the perioperative management of patients with glioblastoma including tools and surgical adjuncts to maximize extent of resection and minimize poor outcomes.
Identifiants
pubmed: 33223018
pii: S1042-3680(20)30091-7
doi: 10.1016/j.nec.2020.09.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.